Heramed Ltd has released a press release.
Exclusive Agreement Executed with Australian Distributor
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from HeraMED
- Quarterly Activities and CashFlow Report
- US Market Entry Strategy Update
- HMD Update & COVID-19 Opportunities Conference Call
- Company Update - COVID-19 To Accelerate Global Opportunities
- HeraCARE Product Development Update
Later from HeraMED
- Agreement with Freeman Rd & PHI Group - Pilots in Australia
- HMD Raises $2.32 Million and Launches SPP
- Company Presentation - June 2020
- Final Approvals Received to Commence Clinical Study
- Results of Share Purchase Plan Offer
Follow HeraMED into a list and get an email when it puts out news.
Follow HeraMED